About 32,900 results
Open links in new tab
  1. CENTENE SIGNS DEFINITIVE AGREEMENT TO DIVEST MAGELLAN

    Nov 17, 2022 · Upon closing of the transaction, Centene and Evolent will launch a multi-year, national strategic partnership, in which Centene will continue and expand its relationship with Magellan …

  2. CENTENE COMPLETES DIVESTITURE OF MAGELLAN SPECIALTY HEALTH

    Centene Corporation (NYSE: CNC) announced today that it has completed the previously announced divestiture of Magellan Specialty Health to Evolent Health, Inc. (Evolent). We are pleased to reach …

  3. Centene to sell Magellan Specialty Health to Evolent

    Nov 18, 2022 · Centene Corporation has announced that it has signed a definitive agreement to sell Magellan Specialty Health to Evolent Health. Centene said it expects to receive over $750 million in …

  4. Centene to divest Magellan Specialty Health - Fierce Healthcare

    Nov 18, 2022 · Centene has agreed to sell Magellan Specialty Health to Evolent Health, the latest move in its broad value creation plan. The government insurer said in an announcement that it expects to …

  5. CENTENE SIGNS DEFINITIVE AGREEMENT TO DIVEST MAGELLAN

    Nov 17, 2022 · Centene Corporation (NYSE: CNC) has signed an agreement to sell Magellan Specialty Health to Evolent Health, expecting over $750 million in total proceeds. The deal includes $600 …

  6. CENTENE COMPLETES DIVESTITURE OF MAGELLAN SPECIALTY …

    Jan 23, 2023 · Centene acquired Magellan Specialty Health, also known as NIA, in January 2022 as part of its acquisition of Magellan Health, Inc.

  7. CENTENE COMPLETES DIVESTITURE OF MAGELLAN RX | CNC Stock …

    Dec 5, 2022 · Centene Corporation (CNC) has completed the divestiture of Magellan Rx to Prime Therapeutics, aligning with its value creation plan. This move allows Centene to concentrate on its …

  8. CENTENE SIGNS DEFINITIVE AGREEMENT TO DIVEST MAGELLAN

    Nov 17, 2022 · Upon closing of the transaction, Centene and Evolent will launch a multi-year, national strategic partnership, in which Centene will continue and expand its relationship with Magellan...

  9. CENTENE COMPLETES DIVESTITURE OF MAGELLAN SPECIALTY HEALTH

    LOUIS, Jan. 23, 2023 / PRNewswire / -- Centene Corporation (NYSE: CNC) announced today that it has completed the previously announced divestiture of Magellan Specialty Health to Evolent Health, Inc. …

  10. CENTENE SIGNS DEFINITIVE AGREEMENT TO DIVEST MAGELLAN

    LOUIS, November 17, 2022 — Centene Corporation (NYSE: CNC) announced today that it has signed a definitive agreement to sell Magellan Specialty Health to Evolent Health, Inc. (Evolent).